Skip to Main Content

Clinical Psychopharmacology Institute Faculty

The APNA Clinical Psychopharmacology Institute Program Committee has curated a lineup of nationally recognized speakers in psychiatric-mental health nursing, neuroscience, and psychopharmacology for the 2026 program.

This prestigious faculty brings together cutting-edge clinical insight, scientific depth, and holistic nurse perspective.

 

2026 CPI Faculty Selected by Nurses for Nurses

Compton headshot
Wilson Compton, MD, MPE

Deputy Director
National Institute on Drug Abuse (NIDA) of the National Institutes of Health

Keynote Speaker

atabong_3
Anyi Atabong, DNP, PMHNP-BC, FNP-C, PMH-C

CEO & Co-Founder, Capital Multi Health Group; Adjunct Faculty, Georgetown University Berkley School of Nursing and Co-Founder of The Society of PMHNPs of Color

Timing, Treatment, Trust: Shaping the Trajectory of Bipolar Disorder

LSC Alternative Headshot 2024
Lee Cohen, MD

Director, The Ammon-Pinizzotto Center for Women’s Mental Health; Associate Chief of Psychiatry for Philanthropy and Department Communications, Massachusetts General Hospital

Women’s mental health

Oliver Freudenreich portrait
Oliver Freudenreich, MD, FACLP

Professor of Clinical Psychiatry, Harvard Medical School; Co-Director, MGH Psychosis Clinical and Research Program
Massachusetts General Hospital

Treatment as Prevention: Stage-Based Schizophrenia Care

Cpi 2025 Square
David W. Goodman, MD

Assistant Professor of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine

ADHD

Lyons Headshot Dec 2024
Lyons Hardy, EdD, MSN, PMHNP

Associate Professor, Virginia Commonwealth University

Dementia types and psychopharmacology

Addictions LeahyLaura
Laura Leahy DrNP, APRN, FAANP, FAANB

Board Certified Psychiatric & Addictions Advanced Practice Nurse; Founder, APNSolutions, LLC

Revisiting older medications

jeremy-mills
Jeremy Mills, DNP, APRN, PMHNP-BC

Clinical Assistant Professor, Coordinator, Psychiatric-Mental Health Nurse Practitioner Program, University of Tennessee

Treatment for nicotine cessation, including vaping

Rostain
Anthony L. Rostain, MD, MA

Chair, Department of Psychiatry & Behavioral Health, Cooper University Health Care; Professor of Psychiatry & Pediatrics, Cooper Medical School of Rowan University

ADHD & neurodevelopmental disorders across the lifespan

NatalieTaylor_DSCF3245_Duhaime78-Richmond-Creative-Counseling
Natalie Taylor, PMHNP-BC

Medical Director, Wild Oaks & Richmond Creative Counseling

Eating Disorders

ThrasherPIC_2
Tony Thrasher, DO, MBA, CPE, DFAPA

Medical Director of Crisis Services, Milwaukee County Behavioral Health Division

Emergency room psychiatry

Treisman
Glenn J. Treisman, MD, PhD

Eugene Meyer III Professor of Psychiatry & Medicine, Director of AIDS Psychiatry Services, Director of the Pain Treatment Program, Johns Hopkins University School of Medicine, Co-Director of the Amos Food, Body & Mind Center

Psychopharmacology in underserved populations

Cpi 2025 Square
Jared Vega, JD, PMHNP-BC

Psychiatric-Mental Health Nurse Practitioner

Prescribing with Protection: Legal Implications and Documentation for PMHNPs in Psychopharmacology

Kirby Williams
Kirby Williams, MSN, PMHNP-BC

Founder, The PMHNP Source & Beacon Behavioral Health and Consulting; Co-founder, The Society of PMHNPs of Color

Drug-Induced Movement Disorders: From Recognition to Real-World Management